Abstract
The Stent or Surgery Trial is a randomized, controlled trial comparing percutaneous coronary intervention with coronary artery bypass grafting (CABG) for patients with multivessel disease. Initial results at a median follow-up of 2 years showed a survival advantage for patients randomized to CABG. This article reports survival outcome at a median follow-up of 6 years.
| Original language | English |
|---|---|
| Pages (from-to) | 381-8 |
| Number of pages | 8 |
| Journal | Circulation |
| Volume | 118 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 22 Jul 2008 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Aged
- Angina Pectoris
- Angioplasty, Balloon, Coronary
- Coronary Artery Bypass
- Coronary Artery Disease
- Diabetes Mellitus
- Disease Progression
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Proportional Hazards Models
- Survival Rate
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver